Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 116
Selected: 0
NCT IDTitle
NCT00058591Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)
NCT02379520HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
NCT00078533Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant
NCT00840853Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT
NCT07211737NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma
NCT00578903Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia
NCT03774654CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)
NCT03478215Mesenchymal Stromal Cells in Living Donor Kidney Transplantation
NCT00368355T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts
NCT01611298Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR
NCT01953900iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma
NCT00057005Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation
NCT02932956Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)
NCT01447056Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases
NCT01192555Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma
NCT06176690Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
NCT00889954Her2 and TGFBeta Cytotoxic T Cells in Treatment of Her2 Positive Malignancy
NCT03294954GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma
NCT00586391CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL
NCT04401410Anti-SARS Cov-2 T Cell Infusions for COVID 19
NCT01713439Allogeneic Neuroblastoma Cells for Relapsed/ Refractory Neuroblastoma, CYCHEALL
NCT00590083Administration of Virus-Specific Cytotoxic T-Lymphocytes
NCT02108522Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant
NCT02287311Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)
NCT01494103Administration of Donor T Cells With the Caspase-9 Suicide Gene
NCT00579111Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)
NCT00058578Stem Cell Transplant to Treat Patients With Systemic Sclerosis
NCT00058799Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine
NCT02291848Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
NCT01945619Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)
NCT06251544TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer
NCT00458679Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells
NCT01247688Umbilical Cord Blood Transplant for Children With Lymphoid Hematological Malignancies
NCT00048386Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy
NCT02065362TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC
NCT04715191Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
NCT00058604Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs).
NCT01702961Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease
NCT01109095CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM
NCT04377932Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
NCT01205334Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
NCT02973113Nivolumab With Epstein Barr Virus Specific T Cells (EBVSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE)
NCT00040482High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis
NCT02276820Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)
NCT00082225LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL)
NCT01570283ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus
NCT04219163Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen
NCT00056966Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases
NCT03093350TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer
NCT00950846Umbilical Cord Blood Transplant for Congenital Pediatric Disorders